Please assess the completion status of the following clinical trial:

Trial Title: Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Glucocorticosteroid treatment for 12 months at least~* Bone age \< 15 years for a boy and \< 13 years for a girl~* Child measured height \< - 2 SD, Child currently treated by GH~Exclusion Criteria:~* Known diabetes (type 1 or type 2)~* A previous history of intolerance or hypersensitivity to the study drug or to drugs with similar chemical structures

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Somatropin (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).